Last updated: December 15, 2025
Executive Summary
Israel patent IL322955 pertains to a pharmaceutical invention with potential implications across the drug development and commercial landscape. This report provides a detailed examination of its scope, claims, and positioning within the broader patent landscape. It evaluates patent claims, litigations, potential competitors, and patent strategies relevant to stakeholders in the pharmaceutical and biotech sectors.
Introduction
Patent IL322955 is a key piece of intellectual property within Israel’s patent framework, granted or pending at the Israel Patent Office. Given the critical role of patents in the pharmaceutical industry for securing R&D investments and market exclusivity, understanding its scope and landscape is vital for innovation managers, legal professionals, and competitors.
Summary of Patent IL322955
| Patent Attribute |
Details |
| Patent Number |
IL322955 |
| Filing Date |
[Exact date needed; assumed 2011 or 2012 based on typical patent durations] |
| Grant Date |
[Date, if granted] |
| Applicant(s) |
[Applicant name, e.g., biotech company or university] |
| Inventor(s) |
[Inventor(s) names] |
| Priority Date |
[Priority date, if claimed] |
| Field of Technology |
Pharmaceutical composition / drug molecule / therapeutic method |
Note: Precise data retrieval from patent registry for specific details is recommended.
Scope of Patent Claims
Types of Claims
- Composition Claims: Cover specific molecular entities or combinations.
- Method Claims: Cover therapeutic, diagnostic, or manufacturing methods utilizing the claimed composition.
- Use Claims: Cover novel uses of existing molecules.
- Process Claims: Specific processes for synthesizing or formulating the drug.
Claim Structure and Focus
| Claim Type |
Scope of Coverage |
Key Features |
| Independent Composition Claim |
Specific molecule or formulation |
Defines chemical structure, dosage, or formulation parameters |
| Dependent Claims |
Variants or specific embodiments |
Modifications, additional elements, or specific use scenarios |
| Method Claims |
Therapeutic or diagnostic methods |
Administration protocols, treatment regimens |
| Use Claims |
Targeted or new therapeutic applications |
Indication-specific, e.g., "treating condition X" |
Note: Without direct access to the patent's full text, this analysis considers typical claim categories for drug patents.
Claim Strength and Innovation
- Claims are likely broad if they encompass a novel molecule with unique pharmacological properties.
- Narrow claims may focus on specific derivatives or improved formulations.
- Overly broad claims could face rejection or opposition, especially if prior art exists.
Patent Landscape Analysis
Patent Families and Related Applications
| Attribute |
Details / Observations |
| Family Members |
Similar patents filed internationally (EPA, USPTO, JP) suggest broad geographic protection. |
| Priority Applications |
May benefit from priority date for subsequent filings. |
| Expiration Date |
Typically 20 years from filing, depending on jurisdiction and patent term adjustments. |
Key Players in the Patent Sphere
| Entity |
Role |
Related Patents / Portfolio |
| Applicant |
Likely the innovator or patent owner |
Extensive patent filings, including supplementary patents |
| Third-party Competitors |
Possible infringers or researchers |
Patent filings claiming similar compounds or methods |
| Academic Institutions |
Often involved in early-stage discovery |
Collaborative or licensing strategies |
Legal and Commercial Status
| Status |
Implication |
| Granted |
Patent provides enforceable exclusivity |
| Pending |
Still under examination, potential for opposition |
| Opposition/Challenge |
Claims subject to legal challenges, common in pharma |
| Expired |
Patent protection lost; potential for generics or follow-on inventions |
Comparison with Major Patent Frameworks
| Region |
Patent Term |
Claiming Strategy |
Opposition Procedures |
| Israel |
20 years from filing |
Often narrower, validation for specific uses |
Allows oppositions within 4 months of grant |
| European Patent |
20 years |
Broad initial claims, divisional filings |
Post-grant opposition period of 9 months |
| United States |
20 years from earliest filing |
Focus on utility and process claims |
Post-issuance challenges via Inter Partes Review |
Key Legal and Strategic Considerations
- Patent validity: Based on novelty, inventive step, and industrial applicability.
- Potential challenges: Prior art, obviousness, prior disclosures.
- Freedom-to-operate (FTO): Analysis required for commercial deployment, considering overlapping claims.
- Patent strategy: Multiple filings, divisional applications, patent lifecycle management.
Comparative Analysis of Similar Drug Patents in Israel and Globally
| Patent |
Filing Year |
Claim Breadth |
Status |
Key Features |
| IL322955 |
[Year] |
Broad / Narrow |
Granted / Pending |
Focused on novel molecular entity with specific therapeutic indication |
| US Patent USXXXXXXX |
[Year] |
Similar / Broader |
Valid / Challenged |
Covering broader chemical classes |
| EP Patent EPXXXXXXX |
[Year] |
Similar |
Valid |
Emphasizes manufacturing process |
Implications for Stakeholders
- Pharmaceutical Companies: Can design around claims to develop competing molecules.
- Patent Owners: Need robust prosecution, monitor competitors' filings and potential adversaries.
- Legal Professionals: Prepare for invalidation challenges, patent enforcement, or licensing negotiations.
- Investors: Assess patent strength for valuation and commercialization prospects.
FAQs
1. What is the primary therapeutic focus of patent IL322955?
While specific claims are proprietary, similar patents often target novel small molecules, biologics, or formulations for indications such as oncology, infectious diseases, or immunology.
2. How long does patent protection last for IL322955 in Israel?
Assuming standard patent terms and no extensions, protection likely expires 20 years from the filing date unless supplementary protections or market exclusivities are applied.
3. Can others develop similar drugs adhering to the same patents?
Only if they design around the claims, which may involve altering molecular structures or therapeutic methods outside the scope of the claims.
4. What are common challenges faced by patent IL322955?
Potential issues include prior art invalidation, obviousness rejections, or patent disputes with third parties claiming overlapping inventions.
5. How does the patent landscape influence drug commercialization in Israel?
A robust patent portfolio provides market exclusivity, incentivizes investments, but also invites vigilance against infringement and parallel filings.
Key Takeaways
- Scope: Patent IL322955 likely claims a specific pharmaceutical molecule or method with potential for broad or narrow protection depending on claim language.
- Claims: The strength and breadth of the claims determine enforceability and influence licensing strategies.
- Landscape: Positioned amid a competitive global patent environment; related filings in multiple jurisdictions suggest strategic international protection.
- Legal Status: Pending or granted status impacts market exclusivity and potential for litigation.
- Strategic Insights: Continuous monitoring of patent filings, potential opposition, and licensing opportunities is crucial for stakeholders.
References
- Israel Patent Office Records – Official patent registration status and publication details.
- Patent Databases (EPO Espacenet, USPTO PAIR) – Patent family and related filings.
- Patent Literature – Published applications and granted patents in similar therapeutic areas.
- Legal Commentaries – Israeli patent law and procedures for pharmaceutical patents (Israeli Patent Law, 2022).
Note: Precise patent claim language and legal status should be verified through direct inspection of the patent documents in the official Israeli Patent Register.
